Report overview
This report contains market size and forecasts of Lung Cancer Biomarkers in global, including the following market information:
Global Lung Cancer Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lung Cancer Biomarkers Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Lung Cancer Biomarkers companies in 2021 (%)
The global Lung Cancer Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protein Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Biomarkers include Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomerieux SA, Merck and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, by Type, 2021 (%)
Protein Biomarker
Genetic Biomarker
Global Lung Cancer Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, by Application, 2021 (%)
Diagnostics
Research
Others
Global Lung Cancer Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Biomarkers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lung Cancer Biomarkers revenues share in global market, 2021 (%)
Key companies Lung Cancer Biomarkers sales in global market, 2017-2022 (Estimated), (Units)
Key companies Lung Cancer Biomarkers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomerieux SA
Merck
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
